Alto Neuroscience, Inc. (ANRO)
18.36
+0.06
(+0.33%)
USD |
NYSE |
Feb 24, 10:28
Alto Neuroscience Total Liabilities (Quarterly) : 35.45M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Halozyme Therapeutics, Inc. | 2.665B |
| Vertex Pharmaceuticals, Inc. | 7.477B |
| Fortress Biotech, Inc. | 116.22M |
| Oramed Pharmaceuticals, Inc. | 18.16M |
| Replimune Group, Inc. | 123.05M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 147.01M |
| Shareholders Equity (Quarterly) | 111.56M |
| Debt to Equity Ratio | 0.2467 |
| Current Ratio | 15.42 |
| Net Debt Paydown Yield | -3.20% |